Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADAM metallopeptidase domain 24, pseudogene (ADAM24P)
- Target
- ADAM24P
- Molecular classification
- Other (Pseudogene; does not encode a functional protein)
01
Overview
ADAM metallopeptidase domain 24, pseudogene (ADAM24P) is a non-functional segment of DNA that resembles the protein-coding gene for ADAM24 but contains disabling mutations that prevent it from encoding a functional protein. It is categorized as a unitary or processed pseudogene and does not translate into an active enzyme or receptor. As with other pseudogenes, ADAM24P has no known role in normal physiology or disease, does not contribute to cell signaling or adhesion, and is not considered a molecular target for pharmacological intervention.
- Other names
- a disintegrin and metalloproteinase domain 24, pseudogeneADAM24ADAM metallopeptidase domain 29 pseudogenea disintegrin and metalloproteinase domain 24, ADAM24P
02
Mechanism of action
None (No known drugs, as above)
03
Biological functions
Other (No known biological function; non-coding pseudogene)
04
Disease associations
Other (No established roles in disease, as typical for pseudogenes)
Beyond the preview
Go deeper on ADAM metallopeptidase domain 24, pseudogene (ADAM24P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ADAM metallopeptidase domain 24, pseudogene (ADAM24P).